|
Volumn 13, Issue 1, 2007, Pages 16-21
|
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAZOLE DERIVATIVE;
CARVEDILOL;
PROPANOLAMINE DERIVATIVE;
AFRICAN AMERICAN;
ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DOSE RESPONSE;
ETHNOLOGY;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
PROSPECTIVE STUDY;
SURVIVAL RATE;
TREATMENT OUTCOME;
UNITED STATES;
ADRENERGIC BETA-ANTAGONISTS;
AFRICAN AMERICANS;
CARBAZOLES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HUMANS;
MALE;
PROPANOLAMINES;
PROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 34247200490
PISSN: 15275299
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1527-5299.2007.888111.x Document Type: Article |
Times cited : (8)
|
References (0)
|